When it comes to prescription drugs, softgels are not often top of mind for formulators. Drug developers tend to lean towards tablets and capsules, perhaps due to perceived simplicity and reliability. Softgels, however, present numerous benefits for both patient and drug developer alike.

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up.

Discussion will also cover Thermo Fisher’s proprietary technology options for innovative Rx softgels and case studies showing the advantages these formulations offer. Save your spot!